Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
COVID-19 Acute Respiratory Distress Syndrome: early-phase trial registry
3 of 6 indexed COVID-19 Acute Respiratory Distress Syndrome trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
COVID-19 Acute Respiratory Distress Syndrome: 6 US clinical trials tracked, 3 recruiting.
COVID-19 Acute Respiratory Distress Syndrome is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The Geneva Foundation, running 2 of these trials.
Enrollment posture brief
Registry condition covid-19-acute-respiratory-distress-syndrome
OPEN 3 | RECR 50% | LATE 0 | EARLY 1 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
COVID-19 Acute Respiratory Distress Syndrome lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for COVID-19 Acute Respiratory Distress Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
COVID-19 Acute Respiratory Distress Syndrome is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates COVID-19 Acute Respiratory Distress Syndrome research.
The Geneva Foundation accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical COVID-19 Acute Respiratory Distress Syndrome enrolment sits around 300 participants.
Median target enrolment is 300 among the 6 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
COVID-19 Acute Respiratory Distress Syndrome research leans observational.
1 interventional and 5 observational studies make up this index (16.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Weill Medical College of Cornell University
NCT05164744
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
Vasomune Therapeutics
NCT05123755
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
The Geneva Foundation
NCT06402318
Post Acute Sequelae of COVID-19
Vanderbilt University Medical Center
NCT04964115
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
The Geneva Foundation
NCT05765396
A Retrospective Study of COVID-19 Treatments
ProgenaBiome
NCT04949230
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on COVID-19 Acute Respiratory Distress Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on COVID-19 Acute Respiratory Distress Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this COVID-19 Acute Respiratory Distress Syndrome page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 COVID-19 Acute Respiratory Distress Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The Geneva Foundation sponsors the most COVID-19 Acute Respiratory Distress Syndrome trials on record, review their full trial history before evaluating a specific study. See The Geneva Foundation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This COVID-19 Acute Respiratory Distress Syndrome condition card totals 6 registered trials; most-linked intervention No Intervention Used; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.